
		FDA APPROVES TRACLEER PULMONARY HYPERTENSION DRUG. : An article from: Biotech Business $5.95


	Tracleer Promising As Digital Ulcer Treatment Actelion Ltd. (SWX: ATLN), Allschwil/Basel, Switzerland, has reported preliminary results from RAPIDS-1, evaluating the efficacy and safety of TracleerTM ... From Worldwide Biotech, 10/1/02

	Medication approved to treat rare lung disorder - Updates - Tracleer - Brief Article The FDA has approved Tracleer (bosentan) tablets to improve the aerobic abilities of people with a rare but fatal lung disorder called pulmonary arterial ... From FDA Consumer, 3/1/02

	New & Approved: Xigris / Paxil / Tracleer Xigris (drotrecogin alfa (activated), Eli Lilly) A genetically engineered version of human activated protein C (a naturally occurring protein), for reducing mortality in adults with severe seps From OB/GYN News, 1/15/02 by Elizabeth Mechcatie

	Sildenafil equal to bosentan in pulmonary hypertension therapy Clinical Question: Is sildenafil (Viagra) more effective than bosentan (Tracleer) in the treatment of patients with class III pulmonary hypertension? From American Family Physician, 10/1/05 by Henry Barry

	Breathe-5: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology PURPOSE: BREATHE-5 was the first placebo-controlled trial to investigate the effects of bosentan (Tracleer[R]) in patients with Eisenmenger physiology ... From CHEST, 10/1/05 by Nazzareno Galie

	Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension Study objectives: Pulmonary arterial hypertension (PAH) leads to substantial morbidity and mortality. Noninvasive parameters in the follow-up assessment ... From CHEST, 10/1/05 by Hanno H. Leuchte

	Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy Rationale: Decreased nitric oxide (NO) is considered an important pathogenetic mechanism in pulmonary arterial hypertension (PAH), but clear evidence is lacking. Objectives: We used multiple techniqu From American Journal of Respiratory and Critical Care Medicine, 8/1/05 by Girgis, Reda E

	Living with PAH Thanks to Susan Simmons Holcomb for her article on pulmonary arterial hypertension (PAH) in the September issue of Nursing2004. I'm a survivor of PAH, ... From Nursing, 11/1/04 by Hammond, Cindy

Home

Contact

Resources

Exchange Links

ebay